Quantcast

Latest Membrane biology Stories

2014-03-27 08:34:12

Cannabinoid Receptor 1 is most recent GPCR to be targeted by RuiYi's iCAPS platform LA JOLLA, Calif. and SHANGHAI, March 27, 2014 /PRNewswire/ -- RuiYi, Inc. announced today a $15 million Series B financing by existing investors: 5AM Ventures, Versant Ventures, Apposite Capital, SR One, the independent corporate healthcare venture capital fund of GlaxoSmithKline, Merck Serono Ventures, the strategic corporate venture fund of Merck Serono, and Aravis SA. RuiYi has a pipeline of...

2014-03-26 04:21:13

LONDON and BOSTON, March 26, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that a company presentation to be given by its Chief Executive Officer, Malcolm Weir, at BioCentury Future Leaders in the Biotech Industry [https://www.biocentury.com/conferences/futureleaders/dates ] on 28 March 2014 will be webcast live. The presentation will take place at 9.30am ET in room 302/303 at the Millennium Broadway...

Heart Attack Patients May Soon Have Side Effect-Free Drug Option
2014-03-12 06:36:52

April Flowers for redOrbit.com - Your Universe Online A new drug designed to stop a heart attack in its tracks, while reducing the damage caused, all without side effects, is one step closer to development thanks to a group of Melbourne scientists from Monash University. New hope for thousands of people who experience heart attacks and heart failure is provided by the study, published in a recent issue of Proceedings of the National Academy of Sciences. A team of scientists, led by...

Detailed Picture Of Protein Linked To Learning, Pain And Brain Disorders Created By Scientists
2014-03-07 11:26:29

Scripps Research Institute Researchers at The Scripps Research Institute (TSRI) and Vanderbilt University have created the most detailed 3-D picture yet of a membrane protein that is linked to learning, memory, anxiety, pain and brain disorders such as schizophrenia, Parkinson's, Alzheimer's and autism. "This receptor family is an exciting new target for future medicines for treatment of brain disorders," said P. Jeffrey Conn, PhD, Lee E. Limbird Professor of Pharmacology and director...

2014-03-07 08:25:11

LONDON and BOSTON, March 7, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that its Chief Executive Officer, Malcolm Weir, will participate in a panel discussion entitled, "Addressing cognitive deficits across CNS disorders: Potential to improve overall functional outcomes and QoL" (2:45pm-3:45pm CET on 10 March) at BIO-Europe Spring 2014 [http://www.ebdgroup.com/bes/index.php ], which takes place in...

Unhealthy Attachments
2014-02-27 13:15:13

University of California - Santa Barbara Using the surface forces apparatus and an atomic force microscope, researchers at UC Santa Barbara have taken a molecular approach to myelin membrane interactions, leading to insights into demyelinating diseases, such as multiple sclerosis. Their research is published in the Proceedings of the National Academy of the Sciences. For a healthy nervous system, axons — the long projections of our nerve cells that run throughout our bodies — must...

Primitive Artificial Cells Turned Into Complex Biological Materials
2014-02-04 15:22:51

University of Southern Denmark It is a big dream in science: To start from scratch with simple artificial microscopic building blocks and end up with something much more complex: living systems, novel computers or every-day materials. For decades scientists have pursued the dream of creating artificial building blocks that can self-assemble in large numbers and reassemble to take on new tasks or to remedy defects. Now researchers from University of Southern Denmark have taken a step...

2014-01-08 04:21:15

WELWYN GARDEN CITY, England and BOSTON, January 8, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR drug discovery and development company, notes that its President, Dan Grau, will moderate a panel discussion entitled "Global Entrepreneurs: Biotech Building Beyond Borders" (1:30-2:00pm Eastern time on 11 January) at the Boston Biotech East/West CEO Conference [http://bbbiotechconference.com/conference-agenda.php?id=14 ], which takes place at the Four Seasons...

Xray Maps GPCR
2013-12-20 12:57:28

redOrbit Staff & Wire Reports - Your Universe Online Researchers have used one of the brightest X-ray sources in the world to map the three-dimensional structure of an important cellular gatekeeper known as a G protein-coupled receptor, or GPCR, in a more natural state than has been previously possible. The new technique, described Friday in the journal Science, is a major leap forward in exploring GPCRs, a vast, hard-to-study family of proteins that plays a key role in human health...

2013-12-18 11:24:32

Innovation could lead to faster drug therapies and increased understanding of proteins on the microscopic level Membrane proteins are the “gatekeepers” that allow information and molecules to pass into and out of a cell. Until recently, the microscopic study of these complex proteins has been restricted due to limitations of “force microscopes” that are available to researchers and the one-dimensional results these microscopes reveal. Now, researchers at the University of Missouri...


Latest Membrane biology Reference Libraries

Esophagus
2013-04-30 13:37:01

The esophagus is the muscular tube that is located between the pharynx and the stomach that aids in digestion during swallowing. Formation and Orientation The esophagus is composed of four separate layers; the mucosa, submucosa, muscularis externa and the adventitia. The mucosa includes the stratified squamous epithelium, lamina propria and muscularis mucosae. The submucosa houses the esophageal glands and connective papillae. The muscularis externa is composed of three sublayers The...

More Articles (1 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related